Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

Overview of attention for article published in BMC Cancer, September 2009

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 21 followers.

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrosp… https://t.co/uGDYnSKAF5

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.